Indywidualna Specjalistyczna Praktyka Lekarska
- Address
- ul. Boleslawa Limanowskiego 15A, 60-744 Poznan, Poland
Indywidualna Specjalistyczna Praktyka Lekarska - Schizophrenia Research Center
This specialized medical practice center focuses on psychiatric research with particular expertise in cognitive impairment associated with schizophrenia. The facility participates in advanced Phase III clinical trials evaluating novel therapeutic interventions for patients with chronic psychiatric conditions.
- Long-term safety monitoring of investigational psychiatric medications
- Cognitive dysfunction in schizophrenia spectrum disorders
- Extension studies for patients completing initial treatment protocols
The center demonstrates commitment to comprehensive patient follow-up through participation in the CONNEX clinical trial program, which evaluates Iclepertin as a potential treatment for cognitive symptoms in schizophrenia. Their involvement in extension trials provides critical long-term safety data that supports the development of new therapeutic options for patients with treatment-resistant psychiatric disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Indywidualna Specjalistyczna Praktyka Lekarska
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Tolerability of BH-200 (Nelivaptan) in V1b-High Outpatients with Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase II Study | HMNC Holding GmbH | Phase II | Not Recruiting | Nov 2024 | Apr 2025 |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Aticaprant | 1 | Unknown | 2023-06-12 | 2023-06-12 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.